John has over 20 years of life sciences business development experience. He has driven dozens of transactions ranging from discovery stage through multi-billion dollar M&A. Prior to founding Shadow Lake Group Inc., John was Director of Business Development & Licensing at Mallinckrodt Pharmaceuticals, where he completed a series of transactions through the company's spin out from Covidien.
John was also Senior Director of Intellectual Property and Licensing at Neuromed Pharmaceuticals. He started his career at the University Industry Liaison Office at the University of British Columbia, where he was responsible for life sciences technology licensing and start-up company formation.